Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle F Clasquin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Protocols in Bioinformatics|March 6, 2012
LC-MS data processing with MAVEN: a metabolomic analysis and visualization engineMichelle F Clasquin, Eugene Melamud, Joshua D Rabinowitz
Metabolites|November 25, 2021
Coupling Mixed Mode Chromatography/ESI Negative MS Detection with Message-Passing Neural Network Modeling for Enhanced Metabolome Coverage and Structural IdentificationGang Xing, Vishnu Sresht, Zhongyuan Sun, et al.
Analytical Chemistry|March 31, 2010
Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometerWenyun Lu, Michelle F Clasquin, Eugene Melamud, et al.
Nature Metabolism|November 30, 2021
Serine catabolism generates liver NADPH and supports hepatic lipogenesisZhaoyue Zhang, Tara TeSlaa, Xincheng Xu, et al.
Nature Communications|August 24, 2023
Structural basis of lipid-droplet localization of 17-beta-hydroxysteroid dehydrogenase 13Shenping Liu, Ruth F Sommese, Nicole L Nedoma, et al.
Cell|June 14, 2011
Riboneogenesis in yeastMichelle F Clasquin, Eugene Melamud, Alexander Singer, et al.
Journal of Lipid Research|August 25, 2024
Murine HSD17β13 does not control liver steatosis and modestly impacts fibrosis in a sex- and diet-specific mannerJustin D Crane, Ornella Barrandon, Bryan Faherty, et al.
Cancer Cell|August 6, 2013
Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancerKrushna C Patra, Qi Wang, Prashanth T Bhaskar, et al.
Cell Reports|April 13, 2016
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 AxisKatya Marjon, Michael J Cameron, Phong Quang, et al.
Cell Reports|October 13, 2016
Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDHEric L Allen, Danielle B Ulanet, David Pirman, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Protocols in Bioinformatics|March 6, 2012
LC-MS data processing with MAVEN: a metabolomic analysis and visualization engineMichelle F Clasquin, Eugene Melamud, Joshua D Rabinowitz
Metabolites|November 25, 2021
Coupling Mixed Mode Chromatography/ESI Negative MS Detection with Message-Passing Neural Network Modeling for Enhanced Metabolome Coverage and Structural IdentificationGang Xing, Vishnu Sresht, Zhongyuan Sun, et al.
Analytical Chemistry|March 31, 2010
Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometerWenyun Lu, Michelle F Clasquin, Eugene Melamud, et al.
Nature Metabolism|November 30, 2021
Serine catabolism generates liver NADPH and supports hepatic lipogenesisZhaoyue Zhang, Tara TeSlaa, Xincheng Xu, et al.
Nature Communications|August 24, 2023
Structural basis of lipid-droplet localization of 17-beta-hydroxysteroid dehydrogenase 13Shenping Liu, Ruth F Sommese, Nicole L Nedoma, et al.
Cell|June 14, 2011
Riboneogenesis in yeastMichelle F Clasquin, Eugene Melamud, Alexander Singer, et al.
Journal of Lipid Research|August 25, 2024
Murine HSD17β13 does not control liver steatosis and modestly impacts fibrosis in a sex- and diet-specific mannerJustin D Crane, Ornella Barrandon, Bryan Faherty, et al.
Cancer Cell|August 6, 2013
Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancerKrushna C Patra, Qi Wang, Prashanth T Bhaskar, et al.
Cell Reports|April 13, 2016
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 AxisKatya Marjon, Michael J Cameron, Phong Quang, et al.
Cell Reports|October 13, 2016
Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDHEric L Allen, Danielle B Ulanet, David Pirman, et al.
Pageof 2